Although the mechanisms by which MS induces inflammation in patients are not fully understood, the release of IFN-γ, predominantly by Th1 cells, increases the expression of IDO in microglia and macrophages [106,107,108,109]. The gene discussed is IDO1; the disease is myeloid sarcoma.